New Haven, CT, United States of America

Genaissance Pharmaceuticals, Inc.


USPTO Granted Patents = 10

% Expired Patents = 60.0

Forward Citations = 315

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Richard S Judson (4 out of 5 patents)

silverMedal J Claiborne Stephens (3 out of 3 patents)

bronzeMedal Andreas Windemuth (2 out of 7 patents)

4.  Marco Guida (2 out of 5 patents)

5.  Jeff Hall (2 out of 3 patents)

6.  Stephen Bryant Liggett (2 out of 16 patents)

7.  Krishnan Nandabalan (1 out of 18 patents)

8.  Gualberto Ruaño (1 out of 2 patents)

9.  R Rex Denton (1 out of 2 patents)

10.  Chuanbo Xu (1 out of 1 patent)

11.  William P Petros (1 out of 1 patent)

12.  Oliver M Colvin (1 out of 1 patent)

13.  Jeffrey R Marks (1 out of 3 patents)

14.  James J Vredenburgh (1 out of 1 patent)

15.  Frank H Ruddle (1 out of 7 patents)


10 patents:

Genaissance Pharmaceuticals, Inc. is a biotechnology company focused on developing personalized medicine solutions. They utilize genomic information to optimize drug discovery and development processes, ultimately leading to more effective and targeted treatments for patients. Their innovative approach has the potential to revolutionize the healthcare industry.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#23 in New Haven, CT

#632 in Connecticut

#29,828 in US

#55,954 in the World

New Haven, CT (US)
New Haven, CT, United States of America
Forward Citations = 315

24 inventors:

Please report any incorrect information to [email protected]
Loading…